PRH Statement to Senate HELP Committee on Gender-Affirming Care
PRH urges Congress to protect evidence-based gender-affirming care for trans youth, families, and providers.
Dr. Urbina Testifies on Harms of ICE
Today, Dr. Josephine Urbina, an ob/gyn in California and Fellow with Physicians for Reproductive Health, is testifying before the Democratic Women’s Caucus in a hearing titled “The Assault of Women By Trump’s ICE & CBP.”
Supreme Court Grants Stay: Mifepristone Access Unchanged, For Now
Today, the Supreme Court of the United States continues to pause Louisiana's attempt to eliminate mifepristone via mail and for pick up at pharmacy while the litigation continues. Dr. Jamila Perritt, ob/gyn in Washington DC and President & CEO of Phy...
Medication abortion isn’t going away, even if access to mifepristone is restricted
President & CEO Dr. Jamila Perritt - "We know for people who are prosecuted for their pregnancy outcomes, a significant proportion of them come to the attention of law enforcement because they sought health care, and a doctor or nurse or social worke...
A Doctor’s Warning From the Front Lines of Reproductive Care
PRH Fellow Dr. Bhaskari Burra - "Anecdotally, I’ve never had anybody experience any adverse effects from mifepristone or any untoward side effects that we weren’t expecting or unexplained complications from taking mifepristone."
PRH Files Amicus Brief to Supreme Court on Mifepristone via Telehealth
On May 5, 2026, Physicians for Reproductive Health, represented by Fried, Frank, Harris, Shriver & Jacobson LLP, filed an amicus brief to the Supreme Court of the United States detailing how critical it is for patients to be able to access mifepristo...